Lactobacillus reuteri Postbiotics Powder - Top China Suppliers & Factory for Quality Probiotics
Deposite: CCTCC M 2020833
Shelf life: 24 months
Storage conditions: Stored at -18℃or lower
Health Benefits
Detailed Information
Postbiotics are derived from the fermentation of qualified raw materials by lactic acid bacteria or probiotics, followed by inactivation of the resulting product. This process may include solid-liquid separation and optional drying treatments.
Lactobacillus reuteri
Lactobacillus reuteri is a type of lactic acid bacterium that has been documented to naturally inhabit the intestines of nearly all vertebrates and mammals. This particular strain, L. reuteri, is characterized by its robust adhesion properties to the intestinal mucosa, which can significantly enhance the distribution of gut microbiota.
By improving the balance of beneficial microorganisms, it effectively counteracts the colonization of pathogenic bacteria and plays a crucial role in the prevention of various intestinal diseases. L. reuteri is also known for producing a broad-spectrum antimicrobial agent called "Reuterin," which has the capability to inhibit the growth of a wide range of microorganisms, including Gram-positive bacteria, Gram-negative bacteria, yeasts, fungi, and pathogenic protozoa.
Probiotic formulations that incorporate L. reuteri are known to bolster human physiological functions and enhance immune responses, thus contributing to overall health and wellness. In 2003, the Ministry of Health in China officially recognized L. reuteri as a microbial strain eligible for inclusion in human health products. As a result, this bacterium is now acknowledged on an international scale as a novel probiotic lactic acid bacterium, possessing substantial theoretical research potential and practical applications in production.
Applications
Food
Dairy
Personal Care
Environmental Protection
Daily Chemicals
Pet
Preservatives
Products List
| Postbiotic Strains | Potency (BCELL/g) |
|---|---|
| Bifidobacterium animalis subsp.lactis | 150 |
| Lactiplantibacillus plantarum | 200 |
| Lacticaseibacillus paracasei | 200 |
| Lacticaseibacillus casei | 200 |
| Lactobacillus acidophilus | 100 |
| Lacticaseibacillus rhamnosus | 300 |
| Bifidobacterium longum subsp. longum | 100 |
| Bifidobacterium longum subsp. infantis | 100 |
| Bifidobacterium breve | 200 |
| Streptococcus salivarius subsp.thermophilus | 100 |
| Limosilactobacillus reuteri | 100 |
| Limosilactobacillus fermentum | 200 |
| Pediococcus acidilactici | 100 |
| Pediococcus pentosaceus | 100 |
Frequently Asked Questions
What are postbiotics and how are they produced?
Postbiotics are derived from the fermentation of qualified raw materials by lactic acid bacteria or probiotics, followed by inactivation of the resulting product. This manufacturing process may include solid-liquid separation and optional drying treatments.
What is Lactobacillus reuteri?
Lactobacillus reuteri is a type of lactic acid bacterium that naturally inhabits the intestines of nearly all vertebrates and mammals. It is well-documented for its robust adhesion properties to the intestinal mucosa, which helps balance gut microbiota and counteract pathogenic colonization.
What is "Reuterin" and what does it do?
Reuterin is a broad-spectrum antimicrobial agent produced by L. reuteri. It has the capability to inhibit the growth of a wide range of microorganisms, including Gram-positive and Gram-negative bacteria, yeasts, fungi, and pathogenic protozoa.
What are the main application fields for postbiotics?
Postbiotics are highly versatile and widely applied in food, dairy, personal care, environmental protection, daily chemicals, pet products, and preservatives.
What product potencies are available and can they be customized?
Standard potencies include 10B Cell/g, 50B Cell/g, and 100B Cell/g. Customized product formulations with different potencies are also fully acceptable to meet specific requirements.
Is Lactobacillus reuteri officially approved for health products?
Yes, in 2003, the Ministry of Health in China officially recognized L. reuteri as a microbial strain eligible for inclusion in human health products. It is globally acknowledged as a novel probiotic lactic acid bacterium with high research and production value.